Search Results - Xiaolan Lu

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    A novel method for detecting SARS-CoV-2 IgM and IgG based on the gold immune chromatography assay by Xiaoqin Yao, Hao Xu, Qin Du, Xiaolan Lu, Qiang Wang

    Published in Scientific Reports (2025-02-01)
    Get full text
    Article


  2. 2

    Nomogram to determine predictive risk for active tuberculosis based on the QuantiFERON-TB Gold In-Tube test by Qiang Wang, Fengdan Zhu, Yanjuan Cai, Tao Zhu, Xiaolan Lu

    Published in Scientific Reports (2023-07-01)
    Get full text
    Article


  3. 3

    Procyanidin B2 induces apoptosis and autophagy in gastric cancer cells by inhibiting Akt/mTOR signaling pathway by Yuqin Li, Xiaolan Lu, Peiying Tian, Kai Wang, Jianping Shi

    Published in BMC Complementary Medicine and Therapies (2021-02-01)
    Get full text
    Article


  4. 4

    DNA Methylation Modification Patterns Identify Distinct Prognosis and Responses to Immunotherapy and Targeted Therapy in Renal Cell Carcinoma by Dan Bai, Yan Cheng, Xiaolan Lu, Ganesh Pandian Namasivayam, Hiroshi Sugiyama

    Published in Frontiers in Bioscience-Landmark (2023-09-01)
    Get full text
    Article


  5. 5

    Prophylactic treatment with Bacteroides uniformis and Bifidobacterium bifidum counteracts hepatic NK cell immune tolerance in nonalcoholic steatohepatitis induced by high fat diet by Jingyuan Xu, Qiaoyun Xia, Ting Wu, Yong Shao, Yatao Wang, Nuyun Jin, Peiying Tian, Longyun Wu, Xiaolan Lu

    Published in Gut Microbes (2024-12-01)
    Get full text
    Article


  6. 6

    A method to alleviate false-positive results of the Elecsys HIV combi PT assay by Xiaolan Lu, Minghong Zhang, Wen Liu, Nan Sheng, Qin Du, Maoxin Zhang, Xiaolan Guo, Guangrong Wang, Qiang Wang

    Published in Scientific Reports (2021-01-01)
    Get full text
    Article


  7. 7

    Circulating miR-200a is a novel molecular biomarker for early-stage renal cell carcinoma by Cheng Wang, Meng Ding, Yuan-Yuan Zhu, Jicheng Hu, Cuiping Zhang, Xiaolan Lu, Jingping Ge, Jun-Jun Wang, Chunni Zhang

    Published in ExRNA (2019-08-01)
    Get full text
    Article


  8. 8

    The prevalence, comorbidities, influencing factors, and identifying factors of non-obese fatty liver disease by Ning Gao, Jiang Deng, Jinhai Wang, Zhihua Zhou, Cong Yao, Mimi Zhou, Xin Xing, Qian Wang, Xiaolan Lu, Haitao Shi

    Published in Frontiers in Medicine (2022-11-01)
    Get full text
    Article


  9. 9

    Population attributable fractions of fatty liver disease for type 2 diabetes Mellitus by Jingyuan Xu, Longyun Wu, Jiang Deng, Longbao Yang, Yatao Wang, Hongyang Tian, Yajun Ji, Qiaoyun Xia, Zhiyi Han, Yan Cheng, Xiaolan Lu

    Published in BMC Endocrine Disorders (2023-09-01)
    Get full text
    Article


  10. 10

    Prevalence and risk factors of metabolic dysfunction-associated fatty liver disease with renal insufficiency in overweight/obese adults by Ameng Shi, Jiang Deng, Juan Ma, Longbao Yang, Xinxing Tantai, Qian Wang, Danyan Chang, Jinhai Wang, Xiaoyan Guo, Xiaolan Lu, Haitao Shi

    Published in Obesity Facts (2023-08-01)
    Get full text
    Article


  11. 11

    Elevated fasting glucose level increases the risk of fatty liver disease: a 10-year study of 31,154 individuals by Jiang Deng, Zhiyi Han, Hailing Tang, Cong Yao, Xiaoling Li, Jingyuan Xu, Mimi Zhou, Xin Xing, Fangxiong Wu, Jianning Li, Xiaolan Lu, Haitao Shi

    Published in BMC Gastroenterology (2022-12-01)
    Get full text
    Article


  12. 12

    Obesity interacts with hyperuricemia on the severity of non-alcoholic fatty liver disease by Mimi Zhou, Nan Yang, Xin Xing, Danyan Chang, Juan Li, Jiang Deng, Yi Chen, Chunhua Hu, Rou Zhang, Xiaolan Lu, Yingren Zhao, Yingli He

    Published in BMC Gastroenterology (2021-01-01)
    Get full text
    Article


Search Tools: